<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="other"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Emerg Trauma Shock</journal-id><journal-id journal-id-type="iso-abbrev">J Emerg Trauma Shock</journal-id><journal-id journal-id-type="publisher-id">JETS</journal-id><journal-title-group><journal-title>Journal of Emergencies, Trauma, and Shock</journal-title></journal-title-group><issn pub-type="ppub">0974-2700</issn><issn pub-type="epub">0974-519X</issn><publisher><publisher-name>Medknow Publications &#x00026; Media Pvt Ltd</publisher-name><publisher-loc>India</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">27162435</article-id><article-id pub-id-type="pmc">4843566</article-id><article-id pub-id-type="publisher-id">JETS-9-51</article-id><article-id pub-id-type="doi">10.4103/0974-2700.179458</article-id><article-categories><subj-group subj-group-type="heading"><subject>Expert Commentary</subject></subj-group></article-categories><title-group><article-title>Hematopoietic stem cells: Can it be a therapeutic option for the hematopoietic failure in patients with trauma-hemorrhagic shock?</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Kumar</surname><given-names>Manoj</given-names></name><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Bhoi</surname><given-names>Sanjeev</given-names></name><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Galwankar</surname><given-names>Sagar</given-names></name><xref ref-type="aff" rid="aff2">1</xref></contrib></contrib-group><aff id="aff1">Department of Emergency Medicine, Jai Prakash Narayan Apex Trauma Centre, AIIMS, New Delhi, India</aff><aff id="aff2"><label>1</label>Department of Emergency Medicine, University of Florida Jacksonville Healthcare, Inc., Jacksonville, FL, USA. E-mail: <email xlink:href="sanjeevbhoi@gmail.com">sanjeevbhoi@gmail.com</email></aff><pub-date pub-type="ppub"><season>Apr-Jun</season><year>2016</year></pub-date><volume>9</volume><issue>2</issue><fpage>51</fpage><lpage>52</lpage><history><date date-type="received"><day>18</day><month>12</month><year>2015</year></date><date date-type="accepted"><day>23</day><month>12</month><year>2015</year></date></history><permissions><copyright-statement>Copyright: &#x000a9; Journal of Emergencies, Trauma, and Shock</copyright-statement><copyright-year>2016</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0"><license-p>This is an open access article distributed under the terms of the Creative Commons Attribution NonCommercial ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non commercially, as long as the author is credited and the new creations are licensed under the identical terms.</license-p></license></permissions></article-meta></front><body><p>Hemorrhagic shock (HS) is the third major cause of death in trauma[<xref rid="ref1" ref-type="bibr">1</xref>] with a limited therapeutic option. Fluid, blood component, and control of hemorrhage have been the cornerstone of management. Previous studies reported that resuscitation with fluids and blood products induces reperfusion ischemia due to the production of reactive oxygen species and activation of immune cells.[<xref rid="ref2" ref-type="bibr">2</xref>] Hematopoietic failure and bone marrow (BM) dysfunction have been observed in experimental animals and human following shock and injury.[<xref rid="ref3" ref-type="bibr">3</xref><xref rid="ref4" ref-type="bibr">4</xref>] Impairment of hematopoietic progenitor cells (HPCs) is clinically associated with persistent anemia and patients are susceptible to infection, sepsis, and multiple organ failure.[<xref rid="ref3" ref-type="bibr">3</xref><xref rid="ref4" ref-type="bibr">4</xref><xref rid="ref5" ref-type="bibr">5</xref>]</p><p>HS induces excessive production of inflammatory cytokines which leads to HPCs apoptosis.[<xref rid="ref4" ref-type="bibr">4</xref><xref rid="ref5" ref-type="bibr">5</xref>] Robinson <italic>et al</italic>. reported that tumor necrosis factor-&#x003b1; binds to the receptor on BM, which activates caspase-8 leading to apoptosis in severe trauma.[<xref rid="ref5" ref-type="bibr">5</xref>] Maturation of erythroid progenitor cells was inhibited by interleukin 1 (IL-1), IL-6, IL-8, and transforming growth factor-&#x003b2; in severe trauma.[<xref rid="ref4" ref-type="bibr">4</xref><xref rid="ref5" ref-type="bibr">5</xref>] BM dysfunction is also associated with mobilization of HPCs into the peripheral blood from BM following severe trauma and animal model.[<xref rid="ref6" ref-type="bibr">6</xref>]</p><p>Hematopoietic stem cells (HSCs) are blood cells that differentiate into the myeloid and lymphoid lineage. BM-derived stem and progenitor cells have a capacity for self-renewal, differentiation, survival, migration, and proliferation. Their mobilization is regulated by an extrinsic and intrinsic signal provided by their microenvironment. BM HPCs are thought to be located within specific stromal niches. This specific microenvironment provides soluble factors and cellular interaction required for HPCs proliferation and differentiation. HPCs may move from one niche to another. HSCs can be isolated from the pelvis, femur, sternum, umbilical cord blood, and peripheral blood. Human HSCs are characterized by expression of surface markers of CD34<sup>+</sup>, CD59<sup>+</sup>, Thy1/CD90<sup>+</sup>, CD38<sup>lo/&#x02212;</sup>, C-kit/CD117<sup>+</sup>, lin<sup>&#x02212;</sup>.[<xref rid="ref7" ref-type="bibr">7</xref><xref rid="ref8" ref-type="bibr">8</xref><xref rid="ref9" ref-type="bibr">9</xref>]</p><p>HSCs transplantation has been used as an adjunct treatment of BM failure, hemoglobinopathies, and immune system disorders.[<xref rid="ref9" ref-type="bibr">9</xref><xref rid="ref10" ref-type="bibr">10</xref><xref rid="ref11" ref-type="bibr">11</xref>] Li <italic>et al</italic>. study showed that human hematopoietic stem/progenitor cells (HSPCs) promoted the kidney repair and regeneration using an established ischemia-reperfusion injury model in mice.[<xref rid="ref12" ref-type="bibr">12</xref>] Human CD34+ cells and HSPCs promoted vasculogenesis and osteogenesis in stroke and bone injury.[<xref rid="ref13" ref-type="bibr">13</xref>] However, the experience of HSCs transplantation in trauma is limited. Authors feel HSCs transplantation may be explored as a therapeutic option in various research models of trauma/HS.</p></body><back><ref-list><title>REFERENCES</title><ref id="ref1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>El Sayad</surname><given-names>M</given-names></name><name><surname>Noureddine</surname><given-names>H</given-names></name></person-group><article-title>Recent advances of hemorrhage management in severe trauma</article-title><source>Emerg Med Int</source><year>2014</year><volume>2014</volume><fpage>638956</fpage><pub-id pub-id-type="pmid">24627809</pub-id></element-citation></ref><ref id="ref2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Finfer</surname><given-names>S</given-names></name><name><surname>Liu</surname><given-names>B</given-names></name><name><surname>Taylor</surname><given-names>C</given-names></name><name><surname>Bellomo</surname><given-names>R</given-names></name><name><surname>Billot</surname><given-names>L</given-names></name><name><surname>Cook</surname><given-names>D</given-names></name><etal/></person-group><article-title>Resuscitation fluid use in critically ill adults: An international cross-sectional study in 391 intensive care units</article-title><source>Crit Care</source><year>2010</year><volume>14</volume><fpage>R185</fpage><pub-id pub-id-type="pmid">20950434</pub-id></element-citation></ref><ref id="ref3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sifri</surname><given-names>ZC</given-names></name><name><surname>Kaiser</surname><given-names>VL</given-names></name><name><surname>Ananthakrishnan</surname><given-names>P</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Mohr</surname><given-names>AM</given-names></name><name><surname>Hauser</surname><given-names>CJ</given-names></name><etal/></person-group><article-title>Bone marrow failure in male rats following trauma/hemorrhagic shock (T/HS) is mediated by mesenteric lymph and modulated by castration</article-title><source>Shock</source><year>2006</year><volume>25</volume><fpage>12</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">16369180</pub-id></element-citation></ref><ref id="ref4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Livingston</surname><given-names>DH</given-names></name><name><surname>Anjaria</surname><given-names>D</given-names></name><name><surname>Wu</surname><given-names>J</given-names></name><name><surname>Hauser</surname><given-names>CJ</given-names></name><name><surname>Chang</surname><given-names>V</given-names></name><name><surname>Deitch</surname><given-names>EA</given-names></name><etal/></person-group><article-title>Bone marrow failure following severe injury in humans</article-title><source>Ann Surg</source><year>2003</year><volume>238</volume><fpage>748</fpage><lpage>53</lpage><pub-id pub-id-type="pmid">14578739</pub-id></element-citation></ref><ref id="ref5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robinson</surname><given-names>Y</given-names></name><name><surname>Hostmann</surname><given-names>A</given-names></name><name><surname>Matenov</surname><given-names>A</given-names></name><name><surname>Ertel</surname><given-names>W</given-names></name><name><surname>Oberholzer</surname><given-names>A</given-names></name></person-group><article-title>Erythropoiesis in multiply injured patients</article-title><source>J Trauma</source><year>2006</year><volume>61</volume><fpage>1285</fpage><lpage>91</lpage><pub-id pub-id-type="pmid">17099548</pub-id></element-citation></ref><ref id="ref6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Badami</surname><given-names>CD</given-names></name><name><surname>Livingston</surname><given-names>DH</given-names></name><name><surname>Sifri</surname><given-names>ZC</given-names></name><name><surname>Caputo</surname><given-names>FJ</given-names></name><name><surname>Bonilla</surname><given-names>L</given-names></name><name><surname>Mohr</surname><given-names>AM</given-names></name><etal/></person-group><article-title>Hematopoietic progenitor cells mobilize to the site of injury after trauma and hemorrhagic shock in rats</article-title><source>J Trauma</source><year>2007</year><volume>63</volume><fpage>596</fpage><lpage>600</lpage><pub-id pub-id-type="pmid">18073606</pub-id></element-citation></ref><ref id="ref7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gurudutta</surname><given-names>GU</given-names></name><name><surname>Satija</surname><given-names>NK</given-names></name><name><surname>Singh</surname><given-names>VK</given-names></name><name><surname>Verma</surname><given-names>YK</given-names></name><name><surname>Gupta</surname><given-names>P</given-names></name><name><surname>Tripathi</surname><given-names>RP</given-names></name></person-group><article-title>Stem cell therapy: A novel and futuristic treatment modality for disaster injuries</article-title><source>Indian J Med Res</source><year>2012</year><volume>135</volume><fpage>15</fpage><lpage>25</lpage><pub-id pub-id-type="pmid">22382178</pub-id></element-citation></ref><ref id="ref8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoggatt</surname><given-names>J</given-names></name><name><surname>Pelus</surname><given-names>LM</given-names></name></person-group><article-title>Mobilization of hematopoietic stem cells from the bone marrow niche to the blood compartment</article-title><source>Stem Cell Res Ther</source><year>2011</year><volume>2</volume><fpage>13</fpage><pub-id pub-id-type="pmid">21418553</pub-id></element-citation></ref><ref id="ref9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Atkins</surname><given-names>HL</given-names></name><name><surname>Muraro</surname><given-names>PA</given-names></name><name><surname>van Laar</surname><given-names>JM</given-names></name><name><surname>Pavletic</surname><given-names>SZ</given-names></name></person-group><article-title>Autologous hematopoietic stem cell transplantation for autoimmune disease &#x02013; Is it now ready for prime time?</article-title><source>Biol Blood Marrow Transplant</source><year>2012</year><volume>18</volume><issue>1 Suppl</issue><fpage>S177</fpage><lpage>83</lpage><pub-id pub-id-type="pmid">22226104</pub-id></element-citation></ref><ref id="ref10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Daikeler</surname><given-names>T</given-names></name><name><surname>Kump</surname><given-names>E</given-names></name><name><surname>Stern</surname><given-names>M</given-names></name><name><surname>H&#x000fc;gle</surname><given-names>T</given-names></name><name><surname>Hij</surname><given-names>A</given-names></name><name><surname>Haeuserman</surname><given-names>P</given-names></name><etal/></person-group><article-title>Autologous hematopoietic stem cell transplantation reverses skin fibrosis but does not change skin vessel density in patients with systemic sclerosis</article-title><source>Pathol Biol (Paris)</source><year>2015</year><volume>63</volume><fpage>164</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">26300240</pub-id></element-citation></ref><ref id="ref11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yesilipek</surname><given-names>MA</given-names></name></person-group><article-title>Hematopoietic stem cell transplantation in children</article-title><source>Turk Pediatri Ars</source><year>2014</year><volume>49</volume><fpage>91</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">26078642</pub-id></element-citation></ref><ref id="ref12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>B</given-names></name><name><surname>Cohen</surname><given-names>A</given-names></name><name><surname>Hudson</surname><given-names>TE</given-names></name><name><surname>Motlagh</surname><given-names>D</given-names></name><name><surname>Amrani</surname><given-names>DL</given-names></name><name><surname>Duffield</surname><given-names>JS</given-names></name></person-group><article-title>Mobilized human hematopoietic stem/progenitor cells promote kidney repair after ischemia/reperfusion injury</article-title><source>Circulation</source><year>2010</year><volume>121</volume><fpage>2211</fpage><lpage>20</lpage><pub-id pub-id-type="pmid">20458011</pub-id></element-citation></ref><ref id="ref13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsumoto</surname><given-names>T</given-names></name><name><surname>Kawamoto</surname><given-names>A</given-names></name><name><surname>Kuroda</surname><given-names>R</given-names></name><name><surname>Ishikawa</surname><given-names>M</given-names></name><name><surname>Mifune</surname><given-names>Y</given-names></name><name><surname>Iwasaki</surname><given-names>H</given-names></name><etal/></person-group><article-title>Therapeutic potential of vasculogenesis and osteogenesis promoted by peripheral blood CD34-positive cells for functional bone healing</article-title><source>Am J Pathol</source><year>2006</year><volume>169</volume><fpage>1440</fpage><lpage>57</lpage><pub-id pub-id-type="pmid">17003498</pub-id></element-citation></ref></ref-list></back></article>